Clinical and Histological Evaluation of Healos® for Alveolar Ridge Augmentation

Sponsor
William Giannobile (Other)
Overall Status
Withdrawn
CT.gov ID
NCT01154868
Collaborator
Johnson & Johnson (Industry)
0
1
1
6
0

Study Details

Study Description

Brief Summary

The purpose of this study is to document and evaluate how a bone graft material (Healos®) can help rebuild bone width. Dental implants can only be placed when enough bone is found and this bone graft may help to rebuild bone width for dental implant placement. The ultimate goal of this study is to evaluate how this graft material can help bone healing.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Alveolar ridge augmentation
Phase 4

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Clinical and Histological Evaluation of Healos® for Alveolar Ridge Augmentation
Study Start Date :
Aug 1, 2010
Anticipated Primary Completion Date :
Feb 1, 2011
Anticipated Study Completion Date :
Feb 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Other: Healos

Procedure: Alveolar ridge augmentation
Under local anesthesia, full-thickness mucoperiosteal flaps will be elevated, followed by degranulation, and collection of all clinical measurements. Crestal and vertical releasing cuts will be performed using diamond-coated discs on the edentulous ridge in need of augmentation. A sequence of bone chisels and osteotomes will be used to split the alveolar ridge in half until a desirable width for implant placement is achieved. Healos® will then be inserted between both osseous plates. Fixation screws will be used as needed to stabilize the expanded alveolar ridge. Collagen barrier membranes (Ossix Plus) will be used to cover the osseous wound. Flaps will be approximated to achieve primary wound closure.
Other Names:
  • Healos
  • Outcome Measures

    Primary Outcome Measures

    1. horizontal (width) bone gain or loss in millimeters. [18 weeks]

    Secondary Outcome Measures

    1. radiographic bone changes measured using computer tomography [18 weeks]

    2. percentage of new bone formation in the alveolar bone core biopsies. [18 weeks]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • age 21 and older

    • 2-4 ADJACENT maxillary front teeth missing

    • require ridge augmentation and dental implant

    • nonsmoker for at least 6 months

    • willing to follow oral hygiene instruction and other study instruction

    • able to read, understand and sign informed consent

    Exclusion Criteria:
    • Residual upper jaw bone equal to or narrower than 3mm.

    • Insufficient gum tissue to obtain wound closure after surgery.

    • Clinically significant or unstable (as defined by the investigators) systemic diseases affecting bone or soft tissue growth; or other kidney, liver, heart, thyroid, blood, autoimmune or acute infectious diseases that makes interpretation of the data more difficult

    • A history of head & neck radiation treatment due to certain medical conditions.

    • Taking steroids, tetracycline or tetracycline analogs, bone therapeutic levels of fluorides, bisphosphonates, medications affecting bone turnover, antibiotics for >7 days or any investigational drug

    • Pregnancy or become pregnant during the length of the study

    • Wearing removable partial dentures that may put pressure over the area where the bone graft will be placed.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Michigan Center for Oral Health Research Ann Arbor Michigan United States 48106

    Sponsors and Collaborators

    • William Giannobile
    • Johnson & Johnson

    Investigators

    • Principal Investigator: William Giannobile, DDS, DMedSc, University of Michigan

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    William Giannobile, William Giannobile, D.D.S., D.Med.Sc., University of Michigan
    ClinicalTrials.gov Identifier:
    NCT01154868
    Other Study ID Numbers:
    • HUM00035937
    First Posted:
    Jul 1, 2010
    Last Update Posted:
    Dec 14, 2015
    Last Verified:
    Dec 1, 2015

    Study Results

    No Results Posted as of Dec 14, 2015